# Japan’s Fish Habit Tied to Fewer Cardiovascular Deaths, With Gains Leveling Off Near 100 Grams a Day **URL:** \ **Category:** News\ **Created:** [November 10, 2026, 3:13am UTC](https://www.rapamycin.news/t/japan-s-fish-habit-tied-to-fewer-cardiovascular-deaths-with-gains-leveling-off-near-100-grams-a-day/27399 "2026-11-10T03:13:18Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![RapAdmin](https://www.rapamycin.news/user_avatar/www.rapamycin.news/rapadmin/32/377_2.png) [@RapAdmin](https://www.rapamycin.news/u/RapAdmin)\ **Post date:** [November 10, 2026, 3:13am UTC](https://www.rapamycin.news/t/japan-s-fish-habit-tied-to-fewer-cardiovascular-deaths-with-gains-leveling-off-near-100-grams-a-day/27399/1 "2026-11-10T03:13:19Z")
![FishConsumptionCardioRisk-2](https://www.rapamycin.news/uploads/default/original/3X/5/a/5a9b078ab0e8a1de959f410e12d2ab47e0b595b7.jpeg) **A systematic review and dose-response meta-analysis pooled prospective cohort studies from Japan, one of the highest fish-consuming countries, to test whether the survival benefits linked to fish in Western populations hold when even the lowest eaters consume fish regularly. Of 16 eligible studies, nine entered the meta-analysis. Comparing the highest with the lowest intake groups, higher fish consumption was associated with a 6% lower risk of death from any cause and a 15% lower risk of cardiovascular death, with almost no disagreement between studies. A spline model suggested risk fell up to about 100 grams per day and then flattened, although formal dose-response tests were not statistically significant.** Japan is one of the few places on Earth where almost nobody avoids fish. That makes it an unusually good test bed for a question nutrition researchers have argued about for decades: do the survival benefits linked to fish in Western studies keep growing as intake climbs, or do they run out? A team from Tohoku University, Kobe University, Japan’s National Institutes of Biomedical Innovation, Health and Nutrition, and the research institute of seafood company Nissui gathered every prospective cohort study of Japanese adults that tracked fish intake and later deaths. After reviewing 113 full-text articles, they found 16 relevant studies and pooled nine. The headline result is consistent but modest. People in the highest fish-intake groups were about 6% less likely to die from any cause during follow-up than those in the lowest groups. For cardiovascular death, the gap was larger, about 15%. Unusually for nutrition research, the individual studies barely disagreed with each other, and removing any single study did not change the picture. The twist is what “low intake” means in Japan. In American and European cohorts, the comparison group often eats almost no fish. In Japan, the bottom group in most studies still ate roughly 18 to 46 grams a day, a couple of servings a week or more. So this analysis asks a sharper question: if you already eat fish, does eating more still help? The answer appears to be a qualified yes. The authors also tried to map the shape of the benefit. A flexible curve fitted to four studies suggested death risk kept falling until about 100 grams a day, around one and a half typical Japanese servings, and then leveled off. Earlier global analyses had placed that plateau nearer 60 grams. However, the formal tests for a dose-response trend were not significant, and the plateau was identified by eye. It is a hypothesis, not a finding. There are reasons for caution beyond the usual “correlation is not causation.” Two studies carry about three-quarters of the statistical weight in each main analysis. For cardiovascular death, the dominant study comes from a cohort that began in the mid-1960s, received the lowest quality score in the set, and, like the second-largest contributor, measured stroke deaths rather than all cardiovascular deaths. The heart-attack evidence is thin. Fish intake was asked about once, at the start, by questionnaire, and people who eat more fish may differ in income, activity and overall diet in ways adjustment cannot fully capture. The authors themselves rate the certainty of the evidence as low. The study was funded by Nissui, and two of the six authors work there. That does not invalidate the analysis, which was preregistered and follows standard methods, but readers should weigh it. What emerges is reassuring rather than revolutionary. Fish appears to remain a sensible part of a long-lived diet even at intakes far above Western norms, with the clearest signal for stroke and cardiovascular death and diminishing returns somewhere near a daily serving. Whether the effect comes from omega-3 fats, protein, vitamin D, taurine, or simply eating less of something else remains open. ### Actionable Insights These are associations, not proven effects, so treat them as reasonable bets rather than guarantees. 1. If you eat little or no fish, moving toward regular intake is the change best supported by this and earlier data. The Japanese results suggest benefit continues up to roughly 100 grams a day (about 700 grams, or six 4-ounce servings, a week), with little extra beyond that. 2. Expect a small individual effect. Moving from the lowest to the highest intake group was linked to about 6% lower relative risk of death from any cause. Applied to the death rate in these cohorts (about 12.6% over 4 to 19 years), that is roughly 0.5 to 0.7 fewer deaths per 100 people, so about 140 to 210 people would need to make the change to avoid one death. In standardized terms that is a Cohen’s d of about 0.03, far below the 0.2 conventionally called “small.” 3. The cardiovascular signal is stronger: 15% lower relative risk, about 0.5 fewer cardiovascular deaths per 100 people, around 200 people per death avoided (d about 0.09). Most of this evidence concerns stroke. 4. Whole fish is not the same as capsules. Fish-oil supplement trials are mixed, so these data do not justify pills as a substitute. 5. At intakes near 100 grams a day, favor low-mercury species such as sardines, salmon, Atlantic or Pacific mackerel and small whole fish. Contaminants were not assessed. ### Context and Source - **Open Access Paper:** [Fish intake and mortality in Japan, a high fish-consuming country: a systematic review and dose-response meta-analysis of cohort studies](https://www.nature.com/articles/s41430-026-01832-0), Published: 23 October 2026. - **Institutions:** Food and Health Science Research Institute, Nissui Corporation (Tokyo); Tohoku University Graduate School of Medicine and Graduate School of Biomedical Engineering (Miyagi); Yokohama University of Pharmacy (Kanagawa); National Institutes of Biomedical Innovation, Health and Nutrition (Osaka, corresponding author Haruki Momma); Kobe University (Hyogo) - **Country:** Japan - **Journal:** European Journal of Clinical Nutrition (Springer Nature) - **Funding and conflicts:** Funded by Nissui Corporation, a major Japanese seafood company; the two lead-listed contributors from Nissui (Yokoi, Kato) are employees. - **Impact evaluation:** The impact score of this journal is 3.2, evaluated against a typical high-end range of 0 to 60+ for top general science and medicine journals, therefore this is a Medium impact journal.